10-QPeriod: Q3 FY2025

Astera Labs, Inc. Quarterly Report for Q3 Ended Sep 30, 2025

Filed November 5, 2025For Securities:ALAB

Summary

Astera Labs, Inc. (ALAB) reported a strong third quarter of 2025, demonstrating significant year-over-year growth. Total revenue surged by 104% to $230.6 million for the three months ended September 30, 2025, and by 128% to $581.9 million for the first nine months of the year, primarily driven by increased unit shipments and a favorable product mix. The company achieved profitability in the current quarter and year-to-date, a significant turnaround from the previous year. This operational improvement is underpinned by robust demand for its Intelligent Connectivity Platform, serving hyperscalers and AI infrastructure needs. Despite increased operating expenses related to headcount growth and R&D initiatives, the company's strategic investments appear to be paying off, with a healthy increase in operating income and a positive net income of $91.1 million for the quarter.

Financial Highlights

47 data points
Beta

Revenue

$230.57M

76.2% Gross Margin

Net Income

$91.11M

39.5% Net Margin

EPS (Diluted)

$0.50

Total Assets

$1.40B

Cash & Equivalents

$141.48M

Free Cash Flow

$65.88M

Financial Statements
Beta
Revenue$230.57M
Cost of Revenue$54.76M
Gross Profit$175.81M
R&D Expenses$78.93M
Operating Expenses$120.41M
Operating Income$55.41M
Net Income$91.11M
EPS (Basic)$0.54
EPS (Diluted)$0.50
Shares Outstanding (Basic)167.44M
Shares Outstanding (Diluted)180.63M

Key Highlights

  • 1Revenue growth accelerated significantly, with a 104% increase in the third quarter of 2025 compared to the prior year, reaching $230.6 million.
  • 2For the nine months ended September 30, 2025, revenue more than doubled, increasing by 128% to $581.9 million.
  • 3The company has transitioned to profitability, reporting a net income of $91.1 million for the third quarter of 2025, a substantial improvement from a net loss in the same period last year.
  • 4Gross margin remains strong, albeit slightly decreased to 76.2% for the quarter, reflecting a favorable product mix shift towards hardware modules.
  • 5Operating expenses increased due to strategic investments in headcount and R&D, but were partially offset by a decrease in non-cash stock-based compensation.
  • 6Cash and cash equivalents, along with marketable securities, stood at a robust $1.13 billion as of September 30, 2025, providing ample liquidity.
  • 7The company reported material weaknesses in internal control over financial reporting, with ongoing remediation efforts.

Frequently Asked Questions

Astera Labs' substantial revenue growth is primarily driven by an increase in overall unit shipments, fueled by high demand for its Aries, Scorpio, and Taurus products. Additionally, a shift in product mix towards higher-priced hardware modules and Scorpio products has contributed to higher average selling prices.

Yes, Astera Labs has achieved profitability. The company reported a net income of $91.1 million for the three months ended September 30, 2025, and $174.2 million for the nine months ended September 30, 2025. This marks a significant turnaround from the net losses reported in the comparable periods of 2024. The company believes its current cash position is sufficient to fund operations for at least the next 12 months and beyond.

The primary concern highlighted is the existence of material weaknesses in the company's internal control over financial reporting, related to inadequate risk assessment processes and information technology general controls. Astera Labs is actively engaged in remediation efforts to address these issues, but they remain unremediated as of the reporting date. Investors should monitor the progress of these remediation efforts.

Stock-based compensation expense has decreased significantly, particularly for the nine-month period ended September 30, 2025, compared to 2024. This decrease is largely due to the recognition of time-based vesting of Restricted Stock Units (RSUs) following the company's IPO in the prior year. While operating expenses have increased due to headcount and R&D, the reduction in stock-based compensation has helped offset some of these increases and contributed positively to net income.